NCT05081986View on ClinicalTrials.gov

Repeated iTBS Cycloserine Motor Plasticity

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

October 6, 2021

Study Completion Date

February 23, 2022

Conditions
Motor Activity
Interventions
DEVICE

Transcranial Magnetic Stimulation

Single-pulse transcranial magnetic stimulation and theta-burst stimulation

DRUG

Cycloserine

Cycloserine 100mg

DRUG

Placebo Oral Tablet

Placebo capsule matched to cycloserine capsule

Trial Locations (1)

T2N 1N4

University of Calgary, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER

NCT05081986 - Repeated iTBS Cycloserine Motor Plasticity | Biotech Hunter | Biotech Hunter